Negative Costimulatory Pathways in Rejection & Tolerance
Negative Costimulatory Pathways in Rejection & Tolerance
批准号:
7263396
负责人:
NADER NAJAFIAN
金额:
$11.91万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2010-05-31
关键词:
AcuteAddressAdverse effectsAlloantigenAllogenicAllograft ToleranceAllograftingAnimal ModelAnimalsAntigensApoptosisAutoimmune ResponsesAutoimmunityBindingBiological AssayBiological ModelsBlocking AntibodiesCD28 geneCD80 geneCD8B1 geneCTLA4 geneCardiacCell DeathCell physiologyCellsChimeric ProteinsChronicClassClonal ExpansionCollaborationsColonCompatibleComplementComplexConditionCytokine ActivationDataDevelopmentDiseaseDown-RegulationEducational CurriculumEnvironmentExperimental ModelsFailureFamilyFrequenciesFutureGene ChipsGene TargetingGenerationsGenesGenus ColaGoalsGraft RejectionGraft SurvivalHeartHeart TransplantationHomologous GeneHumanImmuneImmune responseImmunologyImmunosuppressionImmunotherapyIn VitroInbred BALB C MiceInflammationInflammatoryIslets of Langerhans TransplantationKidneyKnockout MiceKnowledgeLaboratoriesLeadLifeLigandsLymphoidLymphoid TissueMHC Class II GenesMalignant NeoplasmsMediatingMediator of activation proteinMemoryMentored Clinical Scientist Development Award (K08)MentorsMicroarray AnalysisModelingMolecular ProfilingMonoclonal AntibodiesMorphologyMusNumbersOpportunistic InfectionsOrganOrgan TransplantationPaperPathway interactionsPeptidesPharmaceutical PreparationsPhasePhenotypePhysiologicalPlayPositioning AttributePrimatesPrincipal InvestigatorProcessProductionProtein FamilyProtocols documentationRateRegulationReportingResearch PersonnelRodent ModelRoleSignal PathwaySignal TransductionSiteSkinSkin TransplantationSolidSpecificitySurvival RateT memory cellT-Cell ActivationT-LymphocyteTestingTestisTherapeuticTherapeutic immunosuppressionTissuesTransgenic MiceTransgenic OrganismsTransplantationTransplantation ToleranceWithdrawalanergybasecell mediated immune responsechemokineclinically relevantcytokinedesigndesireexpression cloninggraft failureheart allograftimmune functionimmunoregulationin vivoisoimmunityknockout animalknockout genemembermouse modelnovelnovel strategiespreventprogramsreceptorresearch studyresponsesizeskin allografttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aim of my proposal is to examine the in vivo functions and the mechanisms of action of novel inhibitory costimulatory molecules PD-PDL and B7-H3 in allograft rejection with the goal of harnessing their function to achieve allograft tolerance. This topic has great clinical relevance for transplantation in general as blockade of conventional positive T cell costimulatory pathway such as B7-CD28 has not been effective in reproducibly inducing tolerance in stringent murine transplant models as well as in larger animals such as primates. An important theme of my proposal is that harnessing physiologic mechanisms of regulation by novel negative T cell costimulatory pathways in addition to positive T cell costimulatory blockade are critical to achieve tolerance in humans. I have generated extensive data about the role of negative costimulatory pathways CTLA4-B7 and PD-1/PDL in CD4 and CDS mediated alloimmune responses in vivo. I also have promising preliminary data about the role of the recently described member of CD28 family, B7-H3 in a vascularized cardiac model. I plan to extend these studies using a number of unique tools that will enable me to dissect the functions, mechanisms and interactions of negative and positive costimulatory pathways in regulating alloimmune responses in vivo. These include well established animal models, novel gene knockout animals targeting specific costimulatory molecules, agents to target novel costimulatory pathways and finally elegant models of CD8+ and CD4+ TCR transgenic mice that allow tracking of alloreactive T cell responses in vivo. The Mentored Clinical Scientist Development Award will provide me with the critical opportunity to further expand my knowledge in immunology necessary for achieving independence. My mentor's and co-mentor's laboratories provide an ideal environment to accomplish the aims of my project because of their strong background in transplantation immonology, their collaborative momentum and their exemplary didactic and ethical curricula.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TIM molecules and the innate: adaptive interface in alloimmunity
-
批准号:8707632
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2013
-
负责人:NADER NAJAFIAN
-
依托单位:
TIM-3: Galectin-9: A Novel Regulatory Pathway of Alloimmune Activation
-
批准号:8312994
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2011
-
负责人:NADER NAJAFIAN
-
依托单位:
Negative Costimulatory Pathways in Rejection & Tolerance
-
批准号:7433308
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2007
-
负责人:NADER NAJAFIAN
-
依托单位:
Negative Costimulatory Pathways in Rejection & Tolerance
-
批准号:7629565
-
项目类别:
-
资助金额:$12.97万
-
财政年份:2007
-
负责人:NADER NAJAFIAN
-
依托单位:
海外基金